Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-26 @ 10:57 AM
NCT ID: NCT02098408
Eligibility Criteria: Inclusion Criteria: * Age 18-40 yrs. * Fulfill criteria for being at Ultra-High Risk of psychosis (defined by one or more of the following): * Vulnerability (Trait and State Risk Factor) Group: Individuals with a combination of a trait risk factor (schizotypal personality disorder or a family history of psychotic disorder in a first degree relative) and a significant deterioration in functioning, or sustained low functioning during the past year. * Attenuated Psychotic Symptoms (APS) Group: Individuals with sub-threshold (intensity or frequency) positive psychotic symptoms. The symptoms must have been present during the past year. * Brief Limited Intermittent Psychotic Symptoms Group (BLIPS): Individuals with a recent history of frank psychotic symptoms that resolved spontaneously (without antipsychotic medication) within one week. The symptoms must have been present during the past year. * Provided informed consent. Exclusion Criteria: * Past history of a treated or untreated psychotic episode of one week's duration or longer * Psychiatric symptoms that are explained by a physical illness with psychotropic effect or acute intoxication (e.g., cannabis use). * Diagnosis of a serious developmental disorder, e.g,. Asperger's syndrome * Currently receiving treatment with metylphenidate. * Rejects providing informed consent.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 40 Years
Study: NCT02098408
Study Brief:
Protocol Section: NCT02098408